We serve Chemical Name:ethyl 3-iodo-7-methylimidazo[1,2-a]pyridine-2-carboxylate CAS:885276-74-4 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:ethyl 3-iodo-7-methylimidazo[1,2-a]pyridine-2-carboxylate
CAS.NO:885276-74-4
Synonyms:Imidazo[1,2-a]pyridine-2-carboxylicacid,3-iodo-7-methyl-,ethyl ester;3-IODO-7-METHYL-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER
Molecular Formula:C11H11IN2O2
Molecular Weight:330.12200
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:43.60000
Exact Mass:329.98700
LogP:2.42400
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Imidazo[1,2-a]pyridine-2-carboxylicacid,3-iodo-7-methyl-,ethyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-IODO-7-METHYL-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-IODO-7-METHYL-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER Use and application,3-IODO-7-METHYL-IMIDAZO[1,2-A]PYRIDINE-2-CARBOXYLIC ACID ETHYL ESTER technical grade,usp/ep/jp grade.
Related News: Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). ethyl 3-iodo-7-methylimidazo[1,2-a]pyridine-2-carboxylate manufacturer Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). ethyl 3-iodo-7-methylimidazo[1,2-a]pyridine-2-carboxylate supplier Looking after their staff: Airlines are under pressure from their staff, who obviously want to protect themselves. ethyl 3-iodo-7-methylimidazo[1,2-a]pyridine-2-carboxylate vendor Compared with individuals with cancer only, those with ASCVD and with ASCVD and cancer had a significantly higher presence of three of more of these factors (23 and 30 percent, respectively, versus 13 percent). ethyl 3-iodo-7-methylimidazo[1,2-a]pyridine-2-carboxylate factory “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.”